Pharmacological inhibition on the ataxia telangiectasia and Rad3-connected protein serine/threonine kinase (ATR; also referred to as FRAP-related protein (FRP1)) has emerged for a promising method for cancer treatment that exploits synthetic lethal interactions with proteins linked to DNA damage fix, overcomes resistance to other therapies and boosts antitumour immunity. Several https://josepha211kvg3.wikigop.com/user